Inferring structural variant cancer cell fraction

Marek Cmero(The Royal Melbourne Hospital), Paul C. Boutros(University of California, Los Angeles), Clemency Jolly(The Francis Crick Institute), Cheng Soon Ong(Australian National University), Ruben M. Drews(GlaxoSmithKline (United Kingdom)), Ke Yuan(Shenzhen Maternity and Child Healthcare Hospital), Jonas Demeulemeester(The Francis Crick Institute), David D.L. Bowtell(The University of Melbourne), Benjamin J. Raphael(Princeton University), Quaid Morris(Kettering University), Henry Lee-Six(Great Ormond Street Hospital), Yulia Rubanova(Simon Fraser University), Rameen Beroukhim(Broad Institute), Pavana Anur, Salem Malikić(Simon Fraser University), Shaolong Cao(The University of Texas MD Anderson Cancer Center), Ignaty Leshchiner(Broad Institute), Daniel Rosebrock(Broad Institute), Lara Jerman(Endeavor Health), Matthew W. Fittall(University College Hospital), Martin Peifer(University of Cologne), Yupeng Cun(Children's Hospital of Chongqing Medical University), Thomas J. Mitchell(University of Cambridge), Yuan Ji(Endeavor Health), Juhee Lee(Harvard University), Santiago Gonzalez(Broad Institute), David J. Adams(Wellcome Sanger Institute), Jan Schröder(The University of Melbourne), Myron Peto(Oregon Health & Science University), Elizabeth L. Christie(The University of Melbourne), Moritz Gerstung(European Bioinformatics Institute), Ville Mustonen(Carleton College)
Nature Communications
February 5, 2020
Cited by 56


Related Papers